| 1. Domain | 1.1 Scope of the Domain | Boundaries | The range of phenomena the science includes and excludes. | Focuses on how multiple tissues coordinate to form organs with defined architecture, function, and spatial organization. Includes tissue–tissue signaling, mechanical integration, branching morphogenesis, lumen formation, compartmentalization, pattern refinement, and organ-specific assembly rules. Excludes single-tissue morphogenesis unless it directly contributes to higher-order organ structure, and excludes mature organ physiology unless relevant to formation logic. |
| | Scale | The spatial, temporal, or organizational level at which the science operates (e.g., quantum, cellular, social, cosmic). | Operates across cellular, tissue, and organ levels (tens of microns to millimeters); temporal scales from hours (early primordia formation) to days/weeks (organ assembly); organizational scales involving multiple interacting tissue layers (epithelial, mesenchymal, endothelial, neural). |
| 1.2 Ontological Commitments | Entities | The kinds of things assumed to exist within the domain (particles, organisms, agents, fields, etc.). | Tissue primordia, organ buds, epithelial tubes, mesenchymal condensations, vascular networks, neural inputs, signaling centers, morphogen gradients, ECM compartments, lumenal cavities, branching modules. |
| | Properties | The fundamental attributes these entities possess (mass, charge, genotype, preference, etc.). | Tissue identity, inductive potential, mechanical stiffness, adhesion profiles, spatial polarity, lumen pressure, branching frequency, compartment boundaries, pattern anisotropy, cross-tissue signaling responsiveness. |
| | Categories | The basic ontological types used to classify domain elements (substances, processes, relations, structures). | Organ types (tubular, branched, layered, cavity-forming), assembly modules (epithelial–mesenchymal interactions, branching units, lumenogenesis strategies), tissue roles (inductive, supportive, boundary-forming), communication types (paracrine, juxtacrine, mechanical). |
| 1.3 State-Variables | Variables | The measurable or definable properties that describe system conditions. | Spatial position of tissue primordia, signaling-center activity, inter-tissue adhesion strength, ECM density, lumenal pressure, branching angles, compartment-boundary integrity, multi-tissue force distributions, proliferation/renewal rates. |
| | Parameterization | How variables encode and represent the system’s state. | System encoded by 3D spatial maps, organ-specific signaling architectures, branching-morphogenesis equations, lumen-pressure measurements, tissue-tissue adhesion matrices, ECM-composition profiles, and dynamic multi-tissue force-balance fields. |
| 1.4 Admissible Idealizations | Simplifications | Conceptual reductions used to make the domain tractable (point masses, rational agents, perfect gases). | Treating tissues as uniform layers; approximating organs as symmetric shapes; ignoring mechanical or biochemical heterogeneity; assuming deterministic branching; using simplified reaction–diffusion fields; treating ECM as homogeneous; modeling tissue interfaces as sharp boundaries. |
| | Validity Conditions | The limits and contexts in which idealizations hold or break down. | Fail in heterogeneous or asymmetrical organs, tissues with strong regional specialization, organs shaped by stochastic branching, systems with significant ECM anisotropy, or cases requiring precise cell-level detail to capture multi-tissue behavior. |
| 1.5 Domain Assumptions | Structural Assumptions | Background ontological stances such as determinism, continuity, randomness, discreteness. | Organ architecture emerges from coordinated tissue interactions; inductive signals guide structural assembly; mechanical forces stabilize organ form; lumen formation follows conserved mechanochemical rules; boundary cues maintain compartment integrity; cross-tissue feedback ensures robustness. |
| | Implicit Commitments | Unstated but necessary assumptions that shape the field’s conceptual structure. | Assumes tissues maintain identity during assembly, signaling gradients remain interpretable, mechanical coupling remains intact across interfaces, organ geometry evolves gradually, and multi-tissue interactions produce coherent structures rather than stochastic aggregates. |
| 1.6 Internal Coherence Requirements | Consistency | The demand that domain concepts do not contradict one another. | Tissue identity, mechanical forces, spatial gradients, and branching or lumen-formation mechanisms must align; multi-tissue behavior must not contradict known organ-pattern rules; morphogenetic modules must produce anatomically plausible organ structures. |
| | Compatibility | The requirement that entities, variables, and assumptions fit together into a unified descriptive framework. | Signaling networks, tissue mechanics, morphogen gradients, ECM architecture, proliferation patterns, and organ-specific assembly rules must integrate into one unified framework that explains the emergence of fully structured organs. |
| 2. Evidence Layer | 2.1 Observable Phenomena | Observables | The aspects of the domain that can produce detectable signals accessible to measurement. | Tissue primordia positioning, epithelial–mesenchymal interactions, budding and branching events, lumen formation and expansion, compartment-boundary emergence, coordinated tissue flows, ECM deposition patterns, cross-tissue signaling responses, vascular ingression, and organ-shape acquisition over time. |
| | Detection Limits | The boundaries of what can be resolved or sensed by current instruments or methods. | Limited by imaging depth in thick organs, inability to resolve small lumenal spaces, limited temporal resolution for rapid morphogenetic events, weak detection of low-abundance signaling factors, difficulty distinguishing similar tissue layers, and loss of structural integrity during dissection. |
| 2.2 Measurement Systems | Units | Standardized quantifications (meters, seconds, volts, decibels, dollars, etc.) necessary for consistent comparison. | Microns (tissue geometry), µm/min (tissue flow), branching frequency, lumen diameter, ECM density units, signaling intensity levels, pressure units (Pa) for lumenal expansion, adhesion or stiffness measurements, volumetric growth rates. |
| | Instruments | Devices and tools (microscopes, spectrometers, sensors, surveys, detectors) used to produce measurements. | Light-sheet and confocal microscopes, 3D optical tomography, micro-CT for organoids, live reporters for cross-tissue signaling, ECM-labeling tools, traction-force microscopy, AFM for stiffness mapping, micropipette aspiration, laser ablation, multi-photon imaging. |
| 2.3 Operational Definitions | Definitions | Terms defined by specific measurement procedures, ensuring empirical clarity. | Organ bud defined as a morphologically distinct primordium; branching event defined as emergence of new epithelial outgrowth; lumenogenesis defined by cavity initiation and clearing; compartment defined by stable boundary separation; ECM domain defined by region-specific ECM composition. |
| | Procedures | The explicit steps required to perform a measurement in a reproducible way. | 3D imaging of organ primordia, segmentation of tissue layers, labeling epithelial/mesenchymal boundaries, quantifying branching angles and lengths, measuring lumen pressures, mapping ECM distributions, tracking multi-tissue movement, and monitoring signaling molecule gradients. |
| 2.4 Data Acquisition | Protocols | Formal processes for gathering data under controlled or standardized conditions. | Standardized staging of embryos or organoids, repeated 3D imaging sequences, uniform tissue labeling, consistent imaging orientation, calibration of mechanical probes, replicate sampling of organ primordia across developmental stages, and controlled perturbations to isolate cross-tissue effects. |
| | Sampling | Rules determining which subset of the domain is measured and how representative it is. | Sampling across organ regions (proximal/distal, dorsal/ventral), across multiple embryonic or organoid specimens, across developmental timepoints, across tissue layers (epithelial, mesenchymal, endothelial), and across different organ lineages. |
| 2.5 Data Character & Format | Data Types | The form raw evidence takes (time series, spectra, images, counts, qualitative records). | 3D shape reconstructions, lumen-volume datasets, branching morphometry tables, multi-tissue flow fields, ECM-distribution maps, fluorescence intensity profiles, signaling-response matrices, mechanical-property maps, lineage-interaction grids. |
| | Resolution | The granularity or precision with which data is captured. | Determined by imaging depth, voxel resolution, segmentation accuracy, reporter sensitivity, mechanical-sensor calibration, and temporal sampling frequency in dynamic organogenesis events. |
| 2.6 Reliability & Calibration | Calibration | Adjustment procedures ensuring instruments produce accurate results. | Fluorescence normalization, mechanical-probe calibration (AFM, micropipette), drift correction for long-term 3D imaging, volumetric reconstruction alignment, ECM-label validation, intra-sample and inter-sample normalization. |
| | Error Characterization | Identification and quantification of noise, uncertainty, bias, and measurement error. | Identification of segmentation artifacts, optical scattering in deep tissue, misregistration of tissue layers, drift in long-term imaging, variation in organoid geometry, sampling bias across developmental stages, and quantification of technical vs biological noise. |
| 3. Structural Layer | 3.1 Patterns & Regularities | Laws / Relations | Stable, repeatable patterns governing how observables behave across conditions. | Organ buds follow reproducible branching patterns; epithelial–mesenchymal interactions reliably direct growth orientation; lumen expansion correlates with pressure–tension balance; tissue interfaces stabilize along predictable adhesion or signal boundaries; iterative branching obeys geometric scaling rules in many organs. |
| | Invariants | Quantities or properties that remain constant under transformations (symmetries, conservation laws). | Conserved epithelial–mesenchymal induction logic across organs; stable ordering of branching hierarchies; persistent spatial compartment boundaries; invariant lumen-initiation mechanisms (e.g., fluid accumulation, apoptosis clearing); conserved organ-axis polarity patterns. |
| 3.2 Causal Architecture | Mechanisms | Underlying processes or structures that produce the observed regularities. | Paracrine signaling drives tissue induction; mesenchymal cues orient epithelial outgrowth; mechanical forces coordinate multi-tissue deformation; ECM scaffolding maintains organ geometry; feedback loops link signaling to growth, branching, and lumenogenesis; cross-tissue adhesion establishes compartment integrity. |
| | Pathways | Organized sequences of interactions forming a causal chain or network. | Signal induction → epithelial bud formation → mesenchyme-guided growth → branching iteration; apical constriction → tissue bending → lumen formation; ECM deposition → stiffness gradients → directed morphogenesis; vasculature ingression → metabolic support → organ maturation. |
| 3.3 Theoretical Vocabulary | Concepts | Core terms that encode the domain’s structure (force, gene, equilibrium, field). | Organ primordium, induction, epithelial–mesenchymal signaling, branching morphogenesis, lumenogenesis, compartmentalization, ECM scaffolding, tissue polarity, boundary formation, multi-tissue integration, morphogenetic module. |
| | Classifications | Taxonomies, categories, or typologies that organize entities and relations. | Organ types (tubular, branched, layered), branching modes (bifurcation, tip-splitting, side-branching), lumen-formation modes (hollowing, cavitation), tissue roles (inductive, supportive, boundary-forming), interaction types (paracrine, mechanical, structural). |
| 3.4 Formal Representations | Equations | Mathematical constructs expressing laws, relations, or mechanisms. | Branching-generation equations, reaction–diffusion signaling models, pressure–tension balance equations for lumen stability, mechanical force–balance equations across tissues, ECM remodeling models, growth–curvature differential equations. |
| | Models | Structured representations—mathematical, computational, or conceptual—used to predict and explain phenomena. | Branching-morphogenesis simulators, multi-tissue finite-element models, epithelial–mesenchymal induction models, lumen-formation mechanical models, ECM-dependent morphogenesis models, 3D organogenesis computational reconstructions. |
| 3.5 Idealized Structures | Simplified Models | Purposeful abstractions that capture essential dynamics while omitting irrelevant detail. | Treating tissues as uniform sheets or layers; approximating organ buds as symmetric shapes; reducing signaling to single morphogens; ignoring ECM heterogeneity; using linear elasticity; treating branching as deterministic rather than probabilistic. |
| | Limit Conditions | Regimes where specific models or approximations hold (classical vs. quantum, linear vs. nonlinear). | Fail in organs with high asymmetry, stochastic branching, strong regional specialization, dynamic ECM remodeling, or complex lumen-development paths; breakdown occurs when fine-scale cell behaviors dominate over coarse tissue approximations. |
| 3.6 Integrative Frameworks | Unifying Theories | Higher-order structures that connect disparate laws or mechanisms under a coherent whole. | Organ formation emerges from coordinated signaling, mechanical forces, ECM structure, and geometric constraints; multi-tissue assembly integrates induction, symmetry, mechanical coupling, and patterning into a single architectural framework; branching and lumenogenesis unify under conserved mechanochemical principles. |
| | Interdisciplinary Links | Points where the theory connects to adjacent sciences or larger explanatory systems. | Connects to systems biology (multi-signal integration), biomechanics (tissue mechanics), materials science (ECM structure), developmental genetics (inductive pathways), computational modeling (3D organ simulators), and regenerative medicine (organoid engineering). |
| 4. Method Layer | 4.1 Inquiry Design | Experimental Design | Structured plans for manipulating variables to test causal claims. | Perturbing inductive signals (e.g., FGFs, BMPs), altering ECM composition or stiffness, ablating or displacing tissue primordia, blocking lumen formation, manipulating branching cues, genetically modifying epithelial/mesenchymal compartments, and engineering organoids to test causal rules of multi-tissue assembly. |
| | Observational Design | Systematic approaches for gathering non-manipulated data (surveys, field studies, natural experiments). | Tracking natural branching events, monitoring spontaneous epithelial–mesenchymal interactions, imaging lumen initiation, observing tissue alignment and interface formation, and documenting organ-shape changes without manipulation. |
| 4.2 Testing & Validation | Hypothesis Testing | Procedures for evaluating whether evidence supports or contradicts specific claims. | Testing signaling-dependence of branch initiation, validating necessity/sufficiency of inductive tissues, evaluating lumen-pressure vs tension predictions, testing ECM-dependence of organ geometry, and validating branching-rule predictions (e.g., bifurcation frequency). |
| | Replication | The requirement that results be independently reproducible under similar conditions. | Repeating organoid-growth experiments, re-imaging branching morphogenesis, validating ECM-manipulation results, re-running mechanical-probe assays, reconstructing lineage or compartment boundaries with independent methods, and using multiple embryos or organoids. |
| 4.3 Inference & Evaluation | Statistical Inference | Rules for drawing conclusions from noisy or incomplete data. | Estimating branching frequencies, quantifying lumen sizes, modeling growth kinetics, inferring force–balance parameters, assessing tissue-alignment precision, fitting reaction–diffusion or induction models, and quantifying uncertainty in multi-tissue interactions. |
| | Model Comparison | Criteria (fit, simplicity, predictive accuracy, robustness) used to evaluate competing models. | Comparing branching-rule models, continuum vs discrete cellular models, multi-tissue finite-element models, different induction frameworks, ECM-dependent morphogenesis models, and evaluating which model best predicts observed organ architecture. |
| 4.4 Error Management | Error Analysis | Identification and quantification of random and systematic errors. | Identifying segmentation errors in 3D reconstructions, misalignment of tissue boundaries, optical scattering in deep tissues, mechanical probe miscalibration, variability in organoid geometry, and quantifying noise in branching or lumen-measurement data. |
| | Bias Control | Methods for minimizing subjective, instrumental, or procedural biases. | Standardizing organoid-culture conditions, controlling ECM formulation, stabilizing imaging orientation, blinding branching or lumen-scoring analyses, replicating samples across developmental stages, and validating signal/marker specificity. |
| 4.5 Adjudication & Revision | Peer Scrutiny | Collective evaluation of claims through critique, review, and debate. | Reanalyzing branching datasets, revisiting tissue–tissue interaction interpretations, validating inductive-signal dependencies, cross-verifying organ architecture with independent imaging modalities, and adjusting conclusions when datasets conflict. |
| | Theory Revision | Procedures for modifying, replacing, or discarding models based on new evidence. | Updating branching or induction models when new interactions are discovered, revising lumenogenesis mechanisms when alternative pathways emerge, incorporating mechanical or geometric constraints previously overlooked, and modifying multi-tissue frameworks based on new empirical data. |
| 4.6 Integrity Conditions | Transparency | Requirements to disclose methods, data, assumptions, and limitations. | Full disclosure of ECM formulations, culture conditions, imaging parameters, mechanical-probe settings, computational models, segmentation pipelines, and uncertainties; release of raw 3D reconstructions and branching maps when possible. |
| | Ethical Standards | Norms ensuring responsible conduct in experimentation, data handling, and publication. | Ethical handling of embryos and organoid systems, accurate reporting of tissue-interaction data, avoiding selective reporting of successful branching events, compliance with developmental and organoid research regulations, and responsible genetic manipulation. |